C12Y 208/02008
[heparan sulfate]-glucosamine n-sulfotransferase
Official title: [Heparan sulfate]-glucosamine N-sulfotransferase (2.8.2.8)
C12Y208/02008 ([heparan sulfate]-glucosamine n-sulfotransferase) appears on 11 US grants and 25 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 25
- Assignees
- 12
- Inventors
- 44
- Latest grant
- 1 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 1 | 4 |
| 2022 | 1 | 4 |
| 2023 | 8 | 6 |
| 2024 | 1 | 3 |
| 2025 | 0 | 3 |
| 2026 | 0 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for enzymatic sulfurylation of alcohols and amines using bacterium of the family Enterobacteriaceae1 Oct 2024US 12,104,193 B2Ajinomoto Co., Inc.
- Engineered aryl sulfate-dependent enzymes3 Oct 2023US 11,773,382 B2Optimvia, LLC
- Engineered aryl sulfate-dependent enzymes26 Sep 2023US 11,767,518 B2Optimvia, LLC
- Engineered aryl sulfate-dependent enzymes25 Jul 2023US 11,708,567 B2Optimvia, LLC
- Engineered aryl sulfate-dependent enzymes4 Jul 2023US 11,692,180 B2Optimvia, LLC
- Novel therapeutic agent for parkinson's disease8 Oct 2026US 2026/0308542 A1
- Novel peptide derived from ndst3 or ndst4 having deacetylase or sulfotransferase activity23 Jul 2026US 2026/0209724 A1Korea Institute of Science and Technology
- Methods of Production of Heparosan, Heparan Sulfate and Heparin in Yeast18 Jun 2026US 2026/0168001 A1Genhtis Fine Chemicals GmbH
- Method For Constructing Synthesis and Regeneration System Based on APS as Active Sulfonate Donor12 Mar 2026US 2026/0071194 A1Jiangnan University
- Anticoagulant heparin-chondroitin chimeric saccharide molecule as well as preparation method and application thereof12 Jun 2025US 2025/0188506 A1Shandong University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.